STIM
Desconocido
STI-001: Turn Cancer Immunotherapy Effective in Most Patients
STIMUNITY SAS
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
Stimunity is a company that develops disruptive immuno-stimulatory biological drugs to restore the immune system against tumor cells.
Immune...
2019-11-27 - 2020-05-31 | Financiado
2019-11-27 - 2020-05-31 | Financiado
INITIATE: INnate ImmunomeTabolIsm as Antiviral TargEt
STIMUNITY SAS
participó en un
H2020:
H2020-MSCA-ITN-2018
Viral outbreaks and epidemics continue to impose high morbidity and mortality burdens in mankind and animals, emphasizing the urgent need fo...
2019-05-21 - 2023-04-30 | Financiado
2019-05-21 - 2023-04-30 | Financiado
* No se disponen de datos de la empresa actual.